Effect of proactive combination therapy with peritoneal dialysis and hemodialysis on technique survival and mortality
© 2024. The Japanese Society for Artificial Organs..
PURPOSE: Clinically relevant evidence for the timing of starting combination therapy with peritoneal dialysis and hemodialysis remains scarce. We retrospectively examined whether combination therapy during the induction phase of dialysis prolongs peritoneal dialysis duration.
METHODS: This retrospective study includes 160 patients who underwent combination therapy from 20 dialysis facilities. Four groups were categorized: combination at peritoneal dialysis induction (n = 12, Proactive combination group), and combination following peritoneal dialysis durations of < 2 years (n = 65), 2-5 years (n = 70), or > 5 years (n = 13). Differences in technique survival of dialysis, mortality, and hospitalization due to cardiovascular events in the groups were observed.
RESULTS: The Proactive combination group had the longer mean duration of combination therapy (3.18 years) comparing to that of combination therapy following peritoneal dialysis (1.45 years), but total peritoneal dialysis duration was shorter than in control groups (4.02 years). Of the 160 cases in the entire cohort, there were 8 deaths, 18 ischemic heart disease hospitalizations, and 18 stroke hospitalizations. The Proactive group had lower crude mortality rate (0/12 cases, 0.0%) and crude hospitalization rate for ischemic heart disease (1/11, 8.3%) than the other groups. However, this cohort study did not have enough statistical power to adjust for patients' background, and we were unable to fully examine the differences in such clinical outcomes by the timing of initiation of combination therapy.
CONCLUSION: Use of combination therapy in the induction phase might prolong the duration of combination therapy, but is not necessarily effective for prolonging peritoneal dialysis technique survival.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs - (2024) vom: 22. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nagai, Kei [VerfasserIn] |
---|
Links: |
---|
Themen: |
Combined therapy |
---|
Anmerkungen: |
Date Revised 22.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1007/s10047-024-01437-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370041038 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370041038 | ||
003 | DE-627 | ||
005 | 20240323002008.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240323s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10047-024-01437-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1341.xml |
035 | |a (DE-627)NLM370041038 | ||
035 | |a (NLM)38514529 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nagai, Kei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of proactive combination therapy with peritoneal dialysis and hemodialysis on technique survival and mortality |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024. The Japanese Society for Artificial Organs. | ||
520 | |a PURPOSE: Clinically relevant evidence for the timing of starting combination therapy with peritoneal dialysis and hemodialysis remains scarce. We retrospectively examined whether combination therapy during the induction phase of dialysis prolongs peritoneal dialysis duration | ||
520 | |a METHODS: This retrospective study includes 160 patients who underwent combination therapy from 20 dialysis facilities. Four groups were categorized: combination at peritoneal dialysis induction (n = 12, Proactive combination group), and combination following peritoneal dialysis durations of < 2 years (n = 65), 2-5 years (n = 70), or > 5 years (n = 13). Differences in technique survival of dialysis, mortality, and hospitalization due to cardiovascular events in the groups were observed | ||
520 | |a RESULTS: The Proactive combination group had the longer mean duration of combination therapy (3.18 years) comparing to that of combination therapy following peritoneal dialysis (1.45 years), but total peritoneal dialysis duration was shorter than in control groups (4.02 years). Of the 160 cases in the entire cohort, there were 8 deaths, 18 ischemic heart disease hospitalizations, and 18 stroke hospitalizations. The Proactive group had lower crude mortality rate (0/12 cases, 0.0%) and crude hospitalization rate for ischemic heart disease (1/11, 8.3%) than the other groups. However, this cohort study did not have enough statistical power to adjust for patients' background, and we were unable to fully examine the differences in such clinical outcomes by the timing of initiation of combination therapy | ||
520 | |a CONCLUSION: Use of combination therapy in the induction phase might prolong the duration of combination therapy, but is not necessarily effective for prolonging peritoneal dialysis technique survival | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Combined therapy | |
650 | 4 | |a Hemodialysis | |
650 | 4 | |a Peritoneal dialysis | |
650 | 4 | |a Technique survival | |
700 | 1 | |a Ueda, Atsushi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs |d 1997 |g (2024) vom: 22. März |w (DE-627)NLM097535141 |x 1619-0904 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:22 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10047-024-01437-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 22 |c 03 |